JACC: Asia

Why JACC: heart failure?

Editor-in-Chief, JACC: Heart Failure Heart failure continues to be one of the most important conditions in cardiology today. The burden of heart failure in this country alone is associated with 1 million hospitalizations and an annual mortality rate of 10%. Over 5 million Americans are affected by this chronic condition. In addition, it is associated with a tremendous cost to the healthcare sys...

Diversity in JACC.

Best of JACC: Cardiovascular Interventions

OBJECTIVES The purpose of this study was to compare the 1-year outcome between bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST-segment elevation myocardial infarction (STEMI) patients. BACKGROUND The Absorb BVS (Abbott Vascular, Santa Clara, California) is a polymeric scaffold approved for treatment of stable coronary lesions. Limited and not randomized d...

Best of JACC: Cardiovascular Imaging

OBJECTIVES This study investigated whether T1 mapping by cardiac magnetic resonance (CMR) reflects the clinical evolution of disease in myocarditis and supports its diagnosis independently of the disease stages. BACKGROUND Acute viral myocarditis is characterized by a range of intracellular changes due to viral replication and extracellular spill of debris within days of viral infection. Conval...

Is E-biomed the future of JACC?

You have reviewed the data with the research fellow and approved the final version of the manuscript. You are ready to submit it for publication. Accordingly, you click “send” on your computer screen and your manuscript may appear almost immediately on the NIH-sponsored E-biomed and will be available to the entire world through the Internet. This is one aspect of the controversial E-biomed prop...